Transdermal Drug Delivery Market Professional Research Report Highlights of Key Drivers and Market Trends till 2026

Transdermal Drug Delivery Market Professional Research Report Highlights of Key Drivers and Market Trends till 2026

Transdermal drug delivery, a method of applying a drug to unbroken skin. The drug is absorbed continuously through the skin and enters the systemic system. It used particularly for the administration of nicotine, nitroglycerin, scopolamine, testosterone, and contraceptives.

Market Snapshot

This report categorizes the market with various types, applications, companies, and regions. It focuses on the present scenario and the future growth of the global Transdermal Drug Delivery market, especially in regions like North America, Asia-Pacific, Europe, South America, Middle East and Africa.

It is estimated that the CAGR (Compounded Annual Growth Rate) of the world market in the forecast period will reach 7.41%, and the total market value is expected to reach USD 8,377 million in 2026 from USD 5,079 million in 2019.

Get FREE Sample of Transdermal Drug Delivery Market Report at:

https://www.globalmarketmonitor.com/reports/163071-transdermal-drug-delivery-market-report-2019.html#download-sample

Competitive Landscape

Actavis

Actelion

GlaxoSmithKline

Bayer

Mylan Pharmaceuticals

Novartis

Growth Driver

Factors such as growing pharmaceutical industry, increasing global population, rising number of chronic patients are likely to propelling the growth of the transdermal drug delivery market. In addition, technological advancements in transdermal drug delivery systems are expected to support this market’s growth in the coming years. However, drug failures and recalls of transdermal drug delivery systems may hamper the market’s growth to a certain extent.

Purchase a copy of Transdermal Drug Delivery report at:

https://www.globalmarketmonitor.com/reports/163071-transdermal-drug-delivery-market-report-2019.html#download-sample

Regional Overview

Europe is the global market leader at a share of 41.78%. North America is currently leading Asia-Pacific with a share of 27.94% and 18.36%. Europe market is expected to expand at a higher CAGR during the forecast period. U.K. & Germany are the major contributor to the growth of transdermal drug delivery market. The high spending on healthcare and high adoption rate of advance technologies are expected to impel the growth of transdermal drug delivery market in the North America region. U.S. is the prominent market in the region.

Type Overview

The type of the Transdermal Drug Delivery market can be divided into Electric current, Mechanical arrays, Thermal Ablation, Chemical Enhancers, and Others.

Application Overview

The Transdermal Drug Delivery is deployed in various end users: Cardiovascular, CNS, Pain Management, Dermatology, and Others.

Ask for a discount at:

https://www.globalmarketmonitor.com/reports/163071-transdermal-drug-delivery-market-report-2019.html#download-sample

Target Audience:

•     Healthcare organizations

•     Research & Clinical Laboratories

•     Research and Development (R&D) companies

•     Other academic organizations

•     Transdermal drug delivery industry associations

•     Product managers, transdermal drug delivery industry administrator, C-level executives of the industries

•     Market Research and consulting firms

• Base Year: 2018

• Estimated Year: 2019

• Forecast Period: 2019 to 2026

Contact:

Global Market Monitor

One Pierrepont Plaza, 300 Cadman Plaza W, Brooklyn,

NY 11201, USA

Phone: + 1 (347) 467 7721

Email: info@globalmarketmonitor.com

Web Site: https://www.globalmarketmonitor.com